Market Research

Most people are familiar with the term “420,” a day celebrated in cannabis culture, but there’s another significant drug-related celebration this month that often doesn’t get as much attention: Bicycle Day. Bicycle Day, observed on April 19, pays homage to the discovery of LSD’s effects by its inventor, following a peculiar bicycle ride he took…

The burgeoning interest in incorporating psychedelics into therapeutic practices has seen a marked rise over the past few years. Recent studies have revealed the potential benefits of substances like psilocybin, LSD, and ketamine in managing various mental health disorders. Therapists point out that psychedelics help dissolve the individual ego, an outcome sought in many spiritual…

At the recent launch of PsyPal, the first EU-funded clinical research project focused on psychedelic-assisted mental health treatments, MEPs were informed about the innovative strides being made in the field. The project, supported by a €6.5 million grant from Horizon Europe, seeks to explore the therapeutic benefits of psilocybin, particularly for patients in palliative care…

Diabetes, a chronic condition marked by elevated blood sugar levels, is projected to affect over 700 million people globally by 2045. As the prevalence of diabetes continues to rise, researchers are investigating novel approaches to combat its effects. One such approach involves psilocybin, the primary psychoactive component in hallucinogenic mushrooms, which has recently gained attention…